GIRZENVEQ Trademark

Trademark Overview

On Wednesday, July 1, 2020, a trademark application was filed for GIRZENVEQ with the United States Patent and Trademark Office. The USPTO has given the GIRZENVEQ trademark a serial number of 90031306. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 1, 2024. This trademark is owned by Pfizer Inc.. The GIRZENVEQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use
girzenveq

General Information

Serial Number90031306
Word MarkGIRZENVEQ
Filing DateWednesday, July 1, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 6, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 30, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Tuesday, January 2, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 1, 2024ABANDONMENT - NO USE STATEMENT FILED
Friday, May 5, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 4, 2023SOU EXTENSION 5 GRANTED
Friday, April 28, 2023SOU EXTENSION 5 FILED
Thursday, May 4, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, April 28, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, April 26, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, April 26, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 26, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 26, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 26, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, November 4, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 2, 2022SOU EXTENSION 4 GRANTED
Wednesday, November 2, 2022SOU EXTENSION 4 FILED
Wednesday, November 2, 2022SOU TEAS EXTENSION RECEIVED
Saturday, May 14, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 12, 2022SOU EXTENSION 3 GRANTED
Thursday, May 12, 2022SOU EXTENSION 3 FILED
Thursday, May 12, 2022SOU TEAS EXTENSION RECEIVED
Monday, May 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 9, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, May 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, May 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 15, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 13, 2021SOU EXTENSION 2 GRANTED
Wednesday, October 13, 2021SOU EXTENSION 2 FILED
Wednesday, October 13, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, May 5, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 3, 2021SOU EXTENSION 1 GRANTED
Monday, May 3, 2021SOU EXTENSION 1 FILED
Monday, May 3, 2021SOU TEAS EXTENSION RECEIVED
Friday, April 30, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 30, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, April 30, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 30, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 1, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 6, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 6, 2020PUBLISHED FOR OPPOSITION
Wednesday, September 16, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 2, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, August 30, 2020ASSIGNED TO EXAMINER
Thursday, July 30, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, July 4, 2020NEW APPLICATION ENTERED

Related Keywords

girzenveq preparations disorders pharmaceutical treatment hypertension pain stroke cancer growth bone